(Q36883723)

English

A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications.

scientific article published on September 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17634948%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

0 references

1 reference

Europe PubMed Central

A meta-analysis and systematic review of the efficacy and safety of anticoagulants as cancer treatment: impact on survival and bleeding complications (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17634948%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

anticoagulation

1 reference

based on heuristic

inferred from title

systematic review

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17634948%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

author name string

Nicole M Kuderer

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17634948%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Gary H Lyman

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17634948%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Charles W Francis

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17634948%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

language of work or name

0 references

publication date

1 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17634948%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17634948%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

110

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17634948%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17634948%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1149-1161

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17634948%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Heparin, dextran 1000 and metastasis formation after I.V. tumour cell injection in dextran non-sensitive rats

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

21 January 2018

Identifying relevant studies for systematic reviews

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

21 January 2018

Bias in meta-analysis detected by a simple, graphical test

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

21 January 2018

Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence of venous thromboembolism in the year before the diagnosis of cancer in 528,693 adults

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypercoagulability in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology of thrombosis in cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for venous thrombosis in medical inpatients: validation of a thrombosis risk score

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Abnormal coagulation profile in brain tumor patients during surgery.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Deep-vein thrombosis and the incidence of subsequent symptomatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Venous thromboembolism and cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Hypercoagulability preceding cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of anticoagulant drugs on cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of endothelial cells growth induced by heparin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of metastases by anticoagulants

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Anionic dyes, heparin, and heparinoids: the rediscovery of polyanionic tumor inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticoagulants and the development of pulmonary metastases. Anticoagulant effect on the Walker 256 carcinosarcoma in rats

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Evidence for effects of heparin on cell surfaces influencing experimental metastases

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of heparin on the initial phase of metastasis formation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Prophylaxis of metastases formation by unspecific immunologic stimulation associated with heparintherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Angiogenesis Inhibition and Tumor Regression Caused by Heparin or a Heparin Fragment in the Presence of Cortisone

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of experimental liver metastases in the rat by continuous intraportal infusion of 5-fluorouracil and heparin: a pilot study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Augmentation of antimetastatic activity of interferon and tumor necrosis factor by heparin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticoagulant treatment of rats with Walker 256 carcinosarcoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of low molecular weight heparin on intra-abdominal metastasis in a laparoscopic experimental study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Increasing the efficiency of cancer chemotherapy with heparin: "clinical study".

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Heparin and chemotherapy in the management of inoperable lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Anticoagulants in the treatment of small cell carcinoma of the bronchus

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of warfarin anticoagulation on survival in carcinoma of the lung, colon, head and neck, and prostate: Final Report of VA cooperative study # 75

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized trial of anticoagulation with warfarin and of alternating chemotherapy in extensive small-cell lung cancer by the Cancer and Leukemia Group B.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Double-blind randomised trial of a very-low-dose warfarin for prevention of thromboembolism in stage IV breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized trial of chemotherapy and radiation therapy with or without warfarin for limited-stage small-cell lung cancer: a Cancer and Leukemia Group B study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Subcutaneous heparin treatment increases survival in small cell lung cancer. "Petites Cellules" Group

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized clinical trial of combination chemotherapy with and without low-molecular-weight heparin in small cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: the fragmin advanced malignancy outcome study (FAMOUS).

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of low molecular weight heparin on survival in patients with advanced malignancy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Language bias in randomised controlled trials published in English and German.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

The Combination of Estimates from Different Experiments

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Quantifying heterogeneity in a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Measuring inconsistency in meta-analyses

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

The statistical basis of meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Interaction revisited: the difference between two estimates

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Operating characteristics of a rank correlation test for publication bias

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparin and cancer survival: review of the literature and pooled analysis of 1,726 patients treated for at least three months

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Lower mortality in cancer patients treated with low-molecular-weight versus standard heparin

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of subcutaneous low-molecular-weight heparin with intravenous standard heparin in proximal deep-vein thrombosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparins and unfractionated heparin in the treatment of patients with acute venous thromboembolism: results of a meta-analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized comparison of low molecular weight heparin and coumarin derivatives on the survival of patients with cancer and venous thromboembolism

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Can low-molecular-weight heparins improve outcome in patients with cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Blood anticoagulating system and malignant tumours.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparin (reviparin) diminishes tumor cell adhesion and invasion in vitro, and decreases intraperitoneal growth of colonadeno-carcinoma cells in rats after laparoscopy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemotherapy with or without anticoagulation as initial management of patients with operable colorectal cancer: a prospective study with at least 5 years follow-up

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Adjuvant portal liver infusion in colorectal cancer with 5-fluorouracil/heparin versus urokinase versus control. Results of a prospective randomized clinical trial (colorectal adenocarcinoma trial I)

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomised controlled trial of adjuvant chemotherapy by portal-vein perfusion after curative resection for colorectal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Final results of a phase III clinical trial on adjuvant intraportal infusion with heparin and 5-fluorouracil (5-FU) in resectable colon cancer (EORTC GITCCG 1983-1987). European Organization for Research and Treatment of Cancer. Gastrointestinal Tra

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Peri-operative heparin: a possible adjuvant to surgery in colo-rectal cancer?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumor angiogenesis and tissue factor

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Combination antiangiogenesis therapy with marimastat, captopril and fragmin in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of human fibrinolysin on survival of carcinosarcoma 256 Walker cells in the blood

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrin as a component of the tumor stroma: origins and biological significance

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

EFFECT OF INHIBITORS OF FIBRINOLYTIC ENZYMES ON DEVELOPMENT OF PULMONARY METASTASES

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Intracellular Location of Tissue Thromboplastin and Possible Relation to Fibrin Deposits in Human Neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasminogen supports tumor growth through a fibrinogen-dependent mechanism linked to vascular patency

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Fibrin-enhanced endothelial cell organization

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Initiation of proliferative events by human ?-thrombin requires both receptor binding and enzymic activity

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of EGF and thrombin on inositol-containing phospholipids of cultured fibroblasts: stimulation of phosphatidylinositol synthesis by thrombin but not EGF.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Managing thromboembolic disease in the cancer patient: efficacy and safety of antithrombotic treatment options in patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of low-molecular-weight heparin and warfarin for the secondary prevention of venous thromboembolism in patients with cancer: a randomized controlled study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-molecular-weight heparin for the long-term treatment of symptomatic venous thromboembolism: meta-analysis of the randomized comparisons with oral anticoagulants.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Secondary prevention of venous thromboembolic events in patients with active cancer: enoxaparin alone versus initial enoxaparin followed by warfarin for a 180-day period

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized controlled study of heparin and low molecular weight heparin for prevention of deep-vein thrombosis in medical patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Warfarin versus low-molecular-weight heparin therapy in cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

The strengths and limitations of meta-analyses based on aggregate data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

On the equivalence of meta-analysis using literature and using individual patient data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of meta-analysis versus analysis of variance of individual patient data

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22892

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36883723&oldid=2088174991"